Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Diabetes & Metabolic Syndrome
Tirzepatide for Weight Loss: Dual-Pathway GLP-1 Treatment from $399/Month Tirzepatide is the active ingredient in Mounjaro and Zepbound the next-generation weight loss medication that targets both GLP-1 and GIP receptors
BPC-157 and TB-500 is available today with a physicians prescription through Live Vital Last reviewed and updated: May 5, 2026 medically reviewed by Dr
Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: A scientific statement from the American Heart Association
US$ 25.87
:max_bytes(150000):strip_icc()/VWHealth-what-kind-of-doctors-you-should-see-if-youre-on-GLP-1-2-f706d7ea26584b0d919320e98e9b9ff8.jpg)
US$ 22.01
US$ 20.47
US$ 22.27
US$ 20.27
